Definitive Proxy Statement

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

(RULE 14A-101)

 

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a)

of the Securities Exchange Act of 1934

(Amendment No.         )

 

 

Filed by the Registrant x

 

Filed by a Party other than the Registrant ¨

 

Check the appropriate box:

 

¨        Preliminary Proxy Statement

 

x       Definitive Proxy Statement

 

¨        Definitive Additional Materials

 

¨        Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12

  

¨        Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Kewaunee Scientific Corporation

(Name of Registrant as Specified in Its Charter)

 

 


(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

x  No fee required.

 

¨  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

  1)  Title of each class of securities to which transaction applies:

 

 
  2)  Aggregate number of securities to which transaction applies:

 

 
  3)  Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):

 

 
  4)  Proposed maximum aggregate value of transaction:

 

 
  5)  Total fee paid:

 

 

 

¨  Fee paid previously with preliminary materials.

 

¨  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.

 

  1)  Amount Previously Paid:

 

 
  2)  Form, Schedule or Registration Statement No.:

 

 
  3)  Filing Party:

 

 
  4)  Date Filed:

 

 

 


KEWAUNEE SCIENTIFIC CORPORATION

2700 West Front Street

Statesville, North Carolina 28677-2927

 

William A. Shumaker

President and

Chief Executive Officer

 

July 16, 2004

 

TO OUR STOCKHOLDERS:

 

You are cordially invited to attend the Annual Meeting of Stockholders of Kewaunee Scientific Corporation (the “Company”), which will be held on the 37th floor at Harris Trust & Savings Bank, 111 West Monroe Street, Chicago, Illinois, on August 25, 2004, at 10:00 A.M. Central Daylight Time.

 

At the meeting, management will review with you the Company’s past year’s performance and the major developments which occurred during the year. There will be an opportunity for stockholders to ask questions about the Company and its operations. We hope you will be able to join us.

 

To assure that your shares are represented at the meeting, please vote, sign and return the enclosed proxy card as soon as possible. The proxy is revocable and will not affect your right to vote in person if you are able to attend the meeting.

 

The Company’s 2004 Annual Report to Stockholders is enclosed.

 

Sincerely yours,

/s/ William A. Shumaker

 


KEWAUNEE SCIENTIFIC CORPORATION

 


 

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

 

to be held on

August 25, 2004

 

The Annual Meeting of Stockholders of Kewaunee Scientific Corporation will be held on the 37th floor at Harris Trust & Savings Bank, 111 West Monroe Street, Chicago, Illinois, on August 25, 2004, at 10:00 A.M. Central Daylight Time, for the purpose of considering and acting upon the following:

 

  (1) To elect two Class III directors; and

 

  (2) To transact such other business as may properly come before the meeting.

 

Stockholders of record at the close of business on July 6, 2004 will be entitled to vote at the meeting. A list of stockholders will be available for examination by any stockholder for any purpose germane to the meeting, during normal business hours, at the offices of Bell, Boyd & Lloyd LLC, 70 West Madison Street, Chicago, Illinois, for a period of 10 days prior to the meeting.

 

It is important that your shares be represented at the meeting regardless of the size of your holdings. Whether or not you intend to be present at the meeting in person, we urge you to vote, date and sign the enclosed proxy and return it in the envelope provided for that purpose, which does not require postage if mailed in the United States.

 

D. MICHAEL PARKER

Secretary

 

July 16, 2004

 


YOUR VOTE IS IMPORTANT

 

Please vote, date and sign the enclosed proxy and return it

promptly in the enclosed envelope.


 


KEWAUNEE SCIENTIFIC CORPORATION

 

PROXY STATEMENT

 

The enclosed proxy is solicited by the Board of Directors of Kewaunee Scientific Corporation (the “Company”) for use at the annual meeting of stockholders of the Company to be held on the 37th floor of Harris Trust & Savings Bank, 111 West Monroe Street, Chicago, Illinois, on August 25, 2004, at 10:00 A.M. Central Daylight Time, and at any postponements or adjournments thereof. Proxies properly executed and returned in a timely manner will be voted at the meeting in accordance with the directions noted thereon. If no direction is indicated, proxies will be voted for the election of the nominees named herein as directors, and on other matters presented for a vote in accordance with the judgment of the persons acting under the proxies.

 

The Company’s principal executive offices are located at 2700 West Front Street, Statesville, North Carolina 28677-2927 (telephone 704/873-7202).

 

The proxy, together with this Proxy Statement and the accompanying Notice of Annual Meeting of Stockholders, is being mailed to stockholders on, or about, July 16, 2004.

 

ELECTION OF DIRECTORS

 

Two Class III directors are to be elected at the meeting. The Board of Directors, at its meeting on June 23, 2004, upon the recommendation of the Nominating Committee, selected Margaret Barr Bruemmer and Eli Manchester, Jr. as nominees for re-election to serve as directors at the annual meeting, each to serve for three-year terms. Each of the nominees are serving as directors as of the date of this Proxy Statement. The two nominees receiving the greatest number of votes at the annual meeting will be elected directors. Unless a stockholder indicates otherwise on the proxy, proxies will be voted for the election of the two nominees named below. If due to circumstances not now foreseen, either of the nominees becomes unavailable for election, the proxies will be voted for such other person or persons as the Board of Directors may select, or the Board will make an appropriate reduction in the number of directors to be elected.

 

Information on the two nominees for Class III directors and the current Class I and II directors is shown below.

 

Class III directors will serve until the annual meeting of stockholders in 2007. The following directors are currently serving as Class III directors and have been nominated for re-election:

 

MARGARET BARR BRUEMMER, 52, was elected a director of the Company in February 1995. Ms. Bruemmer has been engaged in the practice of law in Milwaukee, Wisconsin as a sole practitioner for more than five years and has been Trustee of the Allis-Chalmers Corporation Product Liability Trust since June 1996.

 

ELI MANCHESTER, JR., 73, was elected a director of the Company in November 1990. He was elected President and Chief Executive Officer of the Company in July 1990. In August 1999 he was elected Chairman of the Board, retaining the position of Chief Executive Officer. In September 2000, he relinquished the position of Chief Executive Officer, retaining the position of Chairman.

 


Class I directors will continue to serve until the annual meeting of stockholders in 2005. The following directors are currently serving as Class I directors:

 

WILEY N. CALDWELL, 77, was elected a director of the Company in 1988. From 1984 to 1992, when he retired, he was President of W.W. Grainger, Inc., a distributor of electrical and mechanical equipment.

 

SILAS KEEHN, 74, was elected a director of the Company in May 2001. From 1981 to 1994, when he retired, he was President of the Federal Reserve Bank of Chicago. He is also a director of the National Futures Association.

 

Class II directors will continue to serve until the annual meeting of stockholders in 2006. The following directors are currently serving as Class II directors:

 

JOHN C. CAMPBELL, JR., 61, was elected a director of the Company in 1973. Since May 1995, Mr. Campbell has been engaged in private consulting. From May 1992 to May 1995, he was Chief Operating Officer, Executive Vice President and a director of Grounds For Play, Inc. of Arlington, Texas, a manufacturer of specialty equipment for children’s playgrounds.

 

JAMES T. RHIND, 82, was elected a director of the Company in 1966. Since January 1, 1993, he has been engaged in the practice of law as of counsel to the law firm of Bell, Boyd & Lloyd LLC, Chicago, Illinois, counsel to the Company. Prior thereto, he was a partner in that firm.

 

WILLIAM A. SHUMAKER, 56, has served as President of the Company since August 1999 and Chief Executive Officer since September 2000. He was elected a director of the Company in February 2000. He served as the Company’s Chief Operating Officer from August 1998, when he was also elected Executive Vice President, until September 2000. He served as General Manager of the Company’s Laboratory Products Group from February 1998 until August 1998. He joined the Company in December 1993 as Vice President of Sales and Marketing.

 

Except as otherwise indicated, each director and nominee has had the principal occupation mentioned above for more than five years. Mr. Campbell is the first cousin of Laura Campbell Rhind, wife of Mr. Rhind.

 

The Board of Directors, under the Company’s bylaws, has set the size of the Board of Directors at seven members, divided into three classes. The Company’s certificate of incorporation provides that the three classes shall be as nearly equal in number as possible.

 

The Board of Directors recommends a vote FOR the election of each

of the foregoing nominees for director.

 

2


Meetings and Committees of the Board

 

The business and affairs of the Company are managed under the direction of the Board of Directors. Members of the Board keep informed of the Company’s business and activities by reports and proposals sent to them periodically and in advance of each Board meeting and reports made to them during these meetings by the President and other Company officers. The Board is regularly advised of actions taken by the Executive Committee and other committees of the Board, as well as significant actions taken by management. Members of management are available at Board meetings and other times to answer questions and discuss issues. During the Company’s fiscal year ended April 30, 2004, the Board of Directors held nine meetings.

 

Currently, the standing committees of the Board of Directors of the Company are the Executive Committee, Audit Committee, Compensation Committee, Financial/Planning Committee, and Nominating Committee. The functions and membership of the committees are described below.

 

The Executive Committee, consisting of Messrs. Rhind (Chairman), Campbell, Manchester and Shumaker and Ms. Bruemmer, exercises the authority of the Board between meetings of the full Board, subject to the limitations of the Delaware General Corporation Law. The Executive Committee met two times during the Company’s last fiscal year.

 

The Audit Committee, consisting of Messrs. Keehn (Chairman), Campbell and Rhind, each an independent director, performs the responsibilities and duties described in the Company’s Audit Committee Charter included as Appendix A to this Proxy Statement and is responsible for annually appointing the independent auditor for the Company, approving services to be performed by the independent auditor, reviewing the independent auditor’s reports, and reviewing the Company’s quarterly and annual financial statements before release to the public. The Audit Committee met seven times during the Company’s last fiscal year. In addition, the Board of Directors has determined that Mr. Keehn, the current Chairman of the Audit Committee, is a “financial expert” within the meaning of the current rules of the Securities and Exchange Commission.

 

The Compensation Committee, consisting of Messrs. Caldwell (Chairman), Keehn and Rhind and Ms. Bruemmer, each an independent director, considers and provides recommendations to the Board of Directors with respect to the compensation (salaries and bonuses) of officers of the Company; short- and long-range compensation programs for officers and other key employees of the Company; benefit programs for all employees of the Company; and stock option grants to key employees. The Compensation Committee also acts as the Stock Option Committee, administering and interpreting the stock option plans for officers and other key employees. The Compensation Committee met three times during the Company’s last fiscal year.

 

The Financial/Planning Committee, consisting of Messrs. Manchester (Chairman), Caldwell, Keehn and Shumaker and Ms. Bruemmer, reviews and provides recommendations to the Board of Directors with respect to the annual budget for the Company, the Company’s strategic plan and the annual budget for capital expenditures. The Financial/Planning Committee also reviews the investment results of the assets of the Company’s retirement plans. The Financial/Planning Committee met three times during the Company’s last fiscal year.

 

The Nominating Committee consisting of Messrs. Rhind (Chairman), Campbell and Ms. Bruemmer, each an independent director, makes recommendations to the full Board with respect to candidates for Board membership, officers of the Company, and Board committee membership. The Nominating Committee does not have a charter. Generally, a diversity of factors such as general business experience, leadership and understanding and achievement in manufacturing, finance or marketing are considered in the nomination process for candidates for Board membership, although neither the Board of

 

3


Directors nor the Nominating Committee has established any specific minimum criteria or qualifications that a nominee must possess. The Nominating Committee will consider as prospective Board nominees persons brought to its attention by officers, directors and stockholders. Proposals may be addressed to the Nominating Committee at the address shown on the cover of this Proxy Statement, attention of the Corporate Secretary. The Nominating Committee will consider candidates proposed by stockholders using the same evaluation criteria as for other candidates. The Nominating Committee met one time during the Company’s last fiscal year.

 

In the Company’s last fiscal year, no director attended less than 75% of the aggregate of all meetings of the Board and all meetings held by committees of the Board on which such director served.

 

The Company does not have a formal policy regarding attendance by members of the Board of Directors at the Annual Meeting of Stockholders, although all directors are encouraged to attend. All members of the Board of Directors attended the Company’s 2003 Annual Meeting of stockholders.

 

Stockholder Communications with the Board of Directors

 

The Board of Directors recommends that any communications from stockholders be in writing and addressed to the Board in care of the Corporate Secretary, 2700 West Front Street, Statesville, North Carolina 28677-2927. The name of any specific intended Board member should be noted in the communication. The Corporate Secretary will forward such correspondence only to the intended recipient if one is noted; however, the Corporate Secretary, prior to forwarding any correspondence, will review the correspondence, and in his discretion, will not forward certain items if they are deemed frivolous, of inconsequential commercial value or otherwise inappropriate for Board consideration.

 

Compensation Committee Interlocks and Insider Participation

 

As noted above, the Compensation Committee consists of Messrs. Caldwell, Keehn and Rhind and Ms. Bruemmer. No executive officer of the Company served as a member of the Compensation Committee or as a director of any other entity, one of whose executive officers serves on the Compensation Committee or is a director of the Company. Mr. Rhind is of counsel to the law firm of Bell, Boyd & Lloyd LLC, which serves as counsel to the Company.

 

Director Compensation

 

Each director who is not an employee of the Company receives for his services as such an annual retainer of $18,000 plus a fee of $1,000 for each day of Board and/or committee meetings attended, a multiple-meeting fee of $1,250 and a $500 fee for telephone meetings. In addition, the Chairmen of the Executive and Compensation Committees receive an annual fee of $2,000, and the Chairman of the Audit Committee receives an annual fee of $3,000. Payment of such fees may be deferred at the request of a director. All directors are reimbursed for their expenses for each Board and committee meeting attended. Under the Company’s 1993 Stock Option Plan for Directors, each of the Company’s non-employee directors was granted a one-time option to purchase at fair market value on the date of the grant, 5,000 shares of the Company’s common stock. These options are exercisable in 25% increments on August 1 of each of the next four years after the date of grant and have since been exercised in full by each director, with the exception of Mr. Keehn, who was granted his option in May 2001.

 

Non-employee directors may also elect to participate in the Company’s health insurance program at the same cost as for employees. During the last fiscal year, Mr. Campbell participated in this program. Directors who are employees of the Company receive no compensation for serving as directors.

 

4


EXECUTIVE COMPENSATION

 

Certain Summary Compensation Information

 

The following table sets forth certain information for each of the fiscal years ended April 30, 2004, April 30, 2003 and April 30, 2002, with respect to the compensation of the Chief Executive Officer and the Company’s four other most highly compensated executive officers (the “named executive officers”) in all capacities in which they served.

 

SUMMARY COMPENSATION TABLE

 

    

Fiscal

Year


                   Long-Term
Compensation Awards


  

All Other

Compensation

($) (1)


Name and Principal Position


      Annual Compensation

   

Securities
Underlying

Options (#)


  
      Salary ($)

   Bonus ($)

   Other ($)

      

William A. Shumaker
President and Chief
Executive Officer

   2004
2003
2002
   275,000
269,500
239,167
   —  
—  
—  
   —  
—  
—  
 
 
 
  —  
10,000
10,000
   13,750
10,780
9,567

D. Michael Parker
Senior Vice President-
Finance, Chief Financial
Officer, Treasurer and
Secretary

   2004
2003
2002
   178,232
170,165
161,833
   —  
—  
—  
   —  
—  
—  
 
 
 
  —  
6,000
6,000
   8,912
6,807
6,473

Kurt P. Rindoks
Vice President-Engineering
& Product Development

   2004
2003
2002
   141,333
137,178
132,002
   —   
—  
44,612
   —  
—  
—  
 
 
 
  —  
3,000
3,000
   7,067
5,487
7,065

James J. Rossi
Vice President-
Human Resources

   2004
2003
2002
   134,333
130,134
125,088
   —  
—  
—  
   —  
—  
—  
 
 
 
  —  
3,000
3,000
   6,717
5,205
5,003

Kenneth E. Sparks (2)
Vice President,
General Manager
Technical Furniture Group

   2004
2003
2002
   140,833
134,167
129,375
   —  
—  
—  
   57,356
—  
—  
(3)
 
 
  —  
3,000
3,000
   7,042
5,367
5,175

(1) The amount listed for each named executive officer consists of the total matching contributions made by the Company during the year on behalf of that executive officer to the Company’s Incentive Savings Plan and Executive Deferred Compensation Plan.

 

(2) Mr. Sparks resigned from the Company as of June 25, 2004.

 

(3) Consists of $36,508 for relocation expenses paid to or on behalf of Mr. Sparks and $20,848 paid on behalf of Mr. Sparks for tax gross-up for relocation expenses in connection with his relocation to the Company’s Statesville, North Carolina facility as a result of the Company’s consolidation of its Texas operations with its Statesville operations.

 

5


Option Grants in Last Fiscal Year

 

The Company did not grant any stock options in fiscal year 2004.

 

Option Exercises and Holdings

 

The following table sets forth certain information with respect to options exercised during fiscal year 2004 by the named executive officers and with respect to options held at the end of the year.

 

AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR

AND OPTION VALUES AT FISCAL YEAR-END

 

     Shares
Acquired
on Exercise


  

Value

Realized ($) (1)


   Number of Securities
Underlying Unexercised
Options at April 30, 2004


   Value of Unexercised
In-the-Money Options
at April 30, 2004 ($) (2)


Name


         Exercisable

   Unexercisable

   Exercisable

   Unexercisable

William A. Shumaker

   —      —      26,125    14,375    21,849    18,253

D. Michael Parker

   1,000    4,090    19,750    8,750    21,939    11,019

Kurt P. Rindoks

   —      —      12,500    4,500    9,964    5,576

James J. Rossi

   2,000    8,715    14,500    4,500    23,534    5,576

Kenneth E. Sparks

   —      —      6,250    4,250    4,208    5,443

(1) Based on the difference between the exercise price and the fair market value of the Company’s stock at the date of exercise.

 

(2) Based on the difference between the closing price of the Company’s stock on April 30, 2004 and the exercise price of the options for each optionee.

 

6


Retirement Plan

 

The named executive officers of the Company participate in the Company’s Retirement Plan. The Retirement Plan provides retirement benefits for participating employees which are calculated with reference to years of service and final average monthly compensation (salary and bonus). The annual benefit amount is calculated as 40% of the 10-year final average annual compensation minus 50% of the Primary Social Security Benefit, all multiplied by a fraction, the numerator of which is the number of years of credited service up to 30 years, and the denominator of which is 30. Participants in the Retirement Plan may elect among several payment alternatives.

 

The following table shows estimated annual benefits payable to employees with the indicated years of service and final average annual compensation. The estimated annual benefits are based upon the assumption that the Retirement Plan will continue in effect, without change, that the participant retires at age 65, and that the participant does not elect any alternate payment option under the Retirement Plan. To the extent ERISA rules restrict the amount otherwise payable under the Plan, the amount in excess of the restrictions will be paid by the Company under the provisions of the Company’s Pension Equalization Plan. At April 30, 2004, the credited years of service under the Retirement Plan for Messrs. Shumaker, Parker, Rindoks, Rossi, and Sparks were 10.6, 13.7, 19.5, 20.5, and 6.6, respectively.

 

Final Average

Compensation


   Years of Service

   10

   15

   20

   25

   30

   35

$500,000

   $ 63,100    $ 94,650    $ 126,200    $ 157,750    $ 189,300    $ 189,300

  400,000

     49,770      74,650      99,530      124,410      149,300      149,300

  300,000

     36,430      54,650      72,860      91,080      109,300      109,300

  200,000

     23,100      34,650      46,200      57,750      69,300      69,300

  100,000

     9,770      14,650      19,530      24,410      29,300      29,300

 


 

In accordance with rules promulgated by the Securities and Exchange Commission, the information included under the captions “Compensation Committee Report on Executive Compensation”, “Audit Committee Report” and “Performance Graph” will not be deemed to be filed or to be proxy soliciting material or incorporated by reference in any prior or future filings by the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934.

 

7


COMPENSATION COMMITTEE REPORT ON EXECUTIVE COMPENSATION

 

The Compensation Committee of the Board, which is composed of four independent directors, considers and provides recommendations to the full Board of Directors with respect to salaries and other compensation programs for executive officers of the Company.

 

The objective of the Company’s executive compensation program is to attract, motivate, reward and retain management talent critical to the Company’s achievement of its objectives. Salaries and other compensation for the Company’s executive officers are based on each executive officer’s responsibilities, level of experience, and performance over time, as well as on the recommendation of the Chief Executive Officer. In order to assure that salaries and compensation remain competitive, the Company subscribes to and consults various published surveys on executive compensation.

 

Section 162(m) of the Internal Revenue Code of 1986, as amended, limits the deduction for federal income tax purposes of certain compensation paid by any publicly-held corporation to its chief executive officer and its four other most highly compensated officers to $1 million per year for each such executive. This deduction limit is not relevant to the Company at the current levels of compensation of its executive officers.

 

Executive Officer Compensation

 

The Company’s compensation program for executive officers has four principal components which are discussed below.

 

Base Salary

 

The Compensation Committee annually reviews the base salaries of executive officers. Prior to the meeting at which the annual review occurs, the Committee is furnished with historical data on the total compensation for each executive, marketplace data for comparable positions at other manufacturing and service companies with generally similar annual sales volume, individual performance appraisals and recommended adjustments by the Chief Executive Officer for each executive officer except himself. The Committee further considers the executive officer’s particular qualifications, level of experience, sustained performance over time, and pay position within his or her established base salary range. These factors are also considered in determining an adjustment to the salary of the Chief Executive Officer. Base salaries are traditionally adjusted as of July 1 of each year.

 

Annual Incentive Compensation

 

All of the Company’s executive officers are eligible to participate in an annual incentive bonus plan, pursuant to which each executive officer is eligible to earn a cash bonus for each fiscal year of the Company, based primarily on the attainment of earnings goals established in the incentive bonus plan and, to a lesser extent, on the executive officer’s achievement of established personal goals to the degree determined by the Board of Directors upon the recommendation of the Chief Executive Officer.

 

At the beginning of each fiscal year, the Board of Directors approves earnings goals for the Company for such year and, upon recommendation of the Compensation Committee, establishes specified percentages of each executive officer’s beginning-of-the-year base salary that will be available for bonuses if the Company and/or its operating businesses achieves specified earnings goals and the executive officer achieves his or her personal goals. The percentages increase as the earnings reach various established levels. No executive officers qualified for cash bonuses under the incentive bonus plan for fiscal year 2004.

 

8


Long-Term Incentive Plans

 

In recent fiscal years, through fiscal year 2003, the Company used stock options as its primary long-term incentive plan for executive officers. Stock option awards were normally made annually in August by the Board of Directors, based on the recommendations of the Chief Executive Officer, with respect to all stock options other than his own, and the Compensation Committee. The exercise price of the granted stock options was the fair market value of the Company’s common stock on the date of the grant. Individual awards were based on an individual’s performance, his or her comparative base salary level and the number of stock option grants previously made.

 

Beginning with fiscal year 2004, the Company has used a performance-based long-term incentive plan, instead of stock options, as its primary long-term incentive plan for its executive officers. This plan provides executive officers an opportunity to receive awards in the form of cash payments at the end of a three-year performance period based upon the occurrence of both (i) the Company’s attainment of specified annual financial goals established by the Board of Directors and (ii) an increase in the market price of the Company’s stock from the beginning to the end of the three-year period.

 

Other Compensation Plans

 

Each of the Company’s executive officers is entitled to receive additional compensation in the form of payments, allocations, or accruals under various group compensation and benefit plans. Benefits under these plans are not directly, or indirectly, tied to employee or Company performance.

 

Chief Executive Officer Compensation

 

The Compensation Committee considers the Chief Executive Officer’s leadership an important factor in the future success of the Company. The compensation of the CEO has traditionally included base salary, annual incentive compensation, long-term incentive compensation, and benefits under various group plans. In establishing Mr. Shumaker’s base salary for each fiscal year, the Compensation Committee considers operating results for the prior year and the outlook for the current year, continued development of the management team, operational improvements, compensation of chief executive officers of other companies with comparable sales, and the price of the Company’s common stock. At Mr. Shumaker’s request, his base salary remained unchanged for fiscal year 2004. The CEO’s annual incentive compensation and long-term incentive compensation are determined pursuant to the Company’s incentive plans for executive officers. Mr. Shumaker did not earn a cash bonus under the annual incentive bonus plan for fiscal year 2004, as the Company did not meet its established earnings goals.

 

Compensation Committee Members

Wiley N. Caldwell, Chairman

Margaret Barr Bruemmer

Silas Keehn

James T. Rhind

 

9


AUDIT COMMITTEE REPORT

 

The Audit Committee is composed of three independent directors and is responsible for overseeing the Company’s financial reporting process and other duties as described in the Audit Committee Charter attached as Appendix A to this Proxy Statement.

 

In fulfilling its oversight responsibilities, the Committee has reviewed and discussed the Company’s audited financial statements for the fiscal year ended April 30, 2004 with management and the Company’s independent auditors. Management of the Company is responsible for those financial statements and the Company’s financial reporting process, including the Company’s system of internal controls. The independent auditors are responsible for expressing an opinion on the conformity of those financial statements with accounting principles generally accepted in the United States. The Committee has discussed with the independent auditors the matters required to be discussed by Statement on Auditing Standards No. 61 relating to the conduct of the audit. The Committee has received the written disclosures and the letter from PricewaterhouseCoopers LLP required by Independence Standards Board Standard No. 1, Independence Discussions with Audit Committees, and has discussed with PricewaterhouseCoopers LLP their independence. The Audit Committee also considered whether the provision of non-audit services by PricewaterhouseCoopers LLP was compatible with maintaining its independence. Based on the Committee’s review of the audited financial statements and the review and discussions described in this paragraph, the Committee recommended to the Board of Directors that the audited financial statements for the fiscal year ended April 30, 2004 be included in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2004 for filing with the Securities and Exchange Commission. All members of the Committee meet the independence requirements established by The Nasdaq Stock Market, Inc.

 

Audit Committee Members

Silas Keehn, Chairman

John C. Campbell, Jr.

James T. Rhind

 

10


PERFORMANCE GRAPH

 

The graph below sets forth a comparison of the Company’s annual stockholder return with the annual stockholder return of (i) the Nasdaq Market Index, and (ii) an index of Nasdaq, non-financial companies with similar market capitalizations to the Company1. The graph is based on an investment of $100 on May 1, 1999 (the first trading day of the Company’s fiscal year beginning on that date) in the Company’s common stock, assuming dividend reinvestment. The graph is not an indicator of the future performance of the Company. Thus, it should not be used to predict the future performance of the Company’s stock. The graph and related data were furnished by CoreData, Richmond, Virginia.

 

Comparison of 5-Year Cumulative Total Return

Kewaunee Scientific Corporation, Nasdaq Market Index

and Similar Market Capitalization Index

 

LOGO


1/ In addition to the Company, the Similar Market Capitalization Index is comprised of the following companies: Amcor Limited; Canterbury Park Holding Corporation; HMG/Courtland Properties Inc.; North Coast Energy, Inc.; P & F Industries, Inc.; TAT Technologies Ltd.; TBA Entertainment Corporation; and VPGI Corp. (formerly Uniview Technologies Corporation). Consistent with the prior year, the Company used for an index companies with a market capitalization similar to that of the Company. The Peer Group index was used because there exists no applicable published industry index or line-of-business index, and the Company does not believe it can reasonably identify a peer group of companies in its industry because the Company’s primary competitors are either divisions of larger corporations or are privately owned.

 

11


AGREEMENTS WITH CERTAIN EXECUTIVES

 

The Company entered into agreements with Messrs. Shumaker, Parker, Rindoks, and Rossi in fiscal year 2000 that provide for the payment of compensation and benefits in the event of termination of their employment within three years following a Change of Control of the Company, as defined in the agreements. Each executive whose employment is so terminated will receive compensation if the termination of his employment was by the Company or its successor without cause, or by the executive for good reason, as defined in the agreements. Upon such a termination of employment within one year following a Change of Control, the Company or its successor will be required to make, in addition to unpaid ordinary compensation and a lump-sum cash payment for certain benefits, a lump-sum cash payment equal to the executive’s annual compensation with respect to Messrs. Rindoks and Rossi and two (2) times the executive’s annual compensation with respect to Messrs. Shumaker and Parker. Upon a termination of employment occurring after the first anniversary, but within three years, of the date of the Change of Control, in addition to unpaid ordinary compensation and a lump-sum cash payment for certain benefits, Messrs. Rindoks and Rossi will be entitled to a lump-sum payment equal to one-half (1/2) of their annual compensation and Messrs. Shumaker and Parker will be entitled to a lump-sum payment equal to their annual compensation.

 

12


SECURITY OWNERSHIP OF DIRECTORS AND EXECUTIVE OFFICERS

 

The following table contains information with respect to the “beneficial ownership” (as defined by the Securities and Exchange Commission) of shares of the Company’s common stock, as of June 30, 2004, by (i) each director and director nominee, (ii) each of the named executive officers and (iii) all directors and executive officers as a group. Except as otherwise indicated by footnote, the shares shown are held directly with sole voting and investment power.

 

Name


   Shares
beneficially
owned (1)


  

Percent
of

class


 

Margaret Barr Bruemmer (2)

   92,119    3.7 %

Wiley N. Caldwell

   5,500    *  

John C. Campbell, Jr. (3)

   41,667    1.7 %

Silas Keehn

   10,000    *  

Eli Manchester, Jr.

   126,000    5.0 %

James T. Rhind (4)

   391,351    15.7 %

William A. Shumaker (5)

   62,786    2.5 %

D. Michael Parker (6)

   40,500    1.6 %

Kurt P. Rindoks

   20,535    *  

James J. Rossi

   25,750    *  

Kenneth E. Sparks

   8,250    *  

Directors and executive officers as a group (11 persons)

   824,458    31.6 %

* Percentage of class is less than 1%.

 

(1) Includes shares which may be acquired within sixty (60) days from June 30, 2004 upon exercise of options by: Mr. Keehn – 5,000; Mr. Manchester – 20,000; Mr. Shumaker – 33,000; Mr. Parker – 24,000; Mr. Rindoks – 14,750; Mr. Rossi – 14,750; Mr. Sparks – 8,250; and all officers and directors as a group – 119,750.

 

(2) Includes 43,135 shares held by Ms. Bruemmer’s husband and 5,850 shares held by two of her children, as to all of which she disclaims beneficial ownership.

 

(3) Includes 16,883 shares held by Mr. Campbell’s wife, as to which shares he disclaims beneficial ownership.

 

(4) Includes 243,079 shares held by Mr. Rhind’s wife, Laura Campbell Rhind, 44,080 shares held by Mrs. Rhind as trustee and beneficiary of a trust under the will of Ruth Haney Campbell, as to which shares Mrs. Rhind shares voting and investment power, 44,910 shares held by two trusts of which Mr. Rhind is sole trustee, and 12,000 shares owned by a charitable foundation of which Mr. and Mrs. Rhind are two of three directors. Mr. Rhind disclaims beneficial ownership of all of such shares.

 

(5) Includes 25,248 shares in which Mr. Shumaker shares voting and investment power.

 

(6) Includes 16,500 shares in which Mr. Parker shares voting and investment power.

 

13


SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS

 

The following table contains information with respect to the “beneficial ownership” (as defined by the Securities and Exchange Commission) of shares of the Company’s common stock, as of June 30, 2004, by each person who is known by management of the Company to have been the “beneficial owner” of more than five percent of such stock as of such date, other than persons identified above under “Security Ownership of Directors and Executive Officers”. Except as otherwise indicated by footnote, the shares shown are held with sole voting and investment power.

 

Name


   Shares
beneficially
owned


   

Percent
of

class


 

Elizabeth B. Gardner

   212,069 (1)   8.5 %

Laura Campbell Rhind

   391,351 (2)   15.8 %

Ernest and Patricia R. Ohnell

   166,700 (3)   6.7 %

(1) Includes 64,093 shares held by Mrs. Gardner as a trustee of certain irrevocable trusts for the benefit of her children, as to which shares she disclaims beneficial ownership, and 12,925 shares held by Mrs. Gardner’s husband. Mrs. Gardner’s address is 42 Logan Terrace, Golf, Illinois 60029.

 

(2) Includes 44,080 shares held as trustee and beneficiary of a trust under the will of Ruth Haney Campbell, as to which shares Mrs. Rhind shares voting and investment power, 92,192 shares held by Mr. Rhind personally or as trustee and 12,000 shares held by a charitable foundation of which Mr. and Mrs. Rhind are two of three directors. Mr. and Mrs. Rhind and a third director share voting and investment power over the shares held by the charitable foundation, but disclaim beneficial ownership of them. Mrs. Rhind’s address is 830 Normandy Lane, Glenview, Illinois 60025.

 

(3) The shares owned by Ernest and Patricia R. Ohnell listed in the table are shown as being owned as of February 29, 2000 according to a Schedule 13D filed with the Securities and Exchange Commission in March 2000. Ernest Ohnell directly owned 127,700 shares and his wife, Patricia Ohnell, directly owned 39,000 shares. The Ohnells’ address is 75 Khakum Road, Greenwich, Connecticut 06831.

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Securities Exchange Act of 1934 requires the Company’s executive officers, directors and 10% stockholders to file reports of ownership with the Securities and Exchange Commission. Such persons also are required to furnish the Company with copies of all Section 16(a) forms they file. Based solely on its review of copies of such forms received by it and inquiries of such persons, other than with respect to one late report filed by James Rossi regarding the sale of 1,077 shares of the Company’s common stock, the Company believes that all such filing requirements applicable to its executive officers, directors and 10% stockholders were complied with.

 

14


INDEPENDENT AUDITORS

 

PricewaterhouseCoopers LLP has been selected by the Audit Committee of the Board of Directors to act as the Company’s independent auditors for the fiscal year ending April 30, 2005. PricewaterhouseCoopers LLP served as independent auditors for the Company for the fiscal year ended April 30, 2004. A representative of PricewaterhouseCoopers LLP is expected to attend the annual meeting and will be afforded an opportunity to make a statement if he desires to do so and to respond to questions by stockholders.

 

Policy on Audit Committee Pre-Approval of Audit and Non-Audit Services

 

The Audit Committee’s policy is to pre-approve all audit and non-audit services to be provided by the Company’s independent auditors on a case-by-case basis. In making such determinations, the Audit Committee considers whether the provision of non-audit services is compatible with maintaining the auditor’s independence. All of the audit and non-audit services provided by the Company’s independent auditors on behalf of the Company in 2004 and 2003 were pre-approved in accordance with this policy.

 

Audit Fees and Non-Audit Fees

 

The following fees were paid or will be paid to PricewaterhouseCoopers LLP for professional services rendered on behalf of the Company related to the past two fiscal years:

 

     2004

   2003

Audit Fees

     79,500      74,000

Audit-Related Fees

     12,500      12,500

Tax Fees

     34,978      26,000
    

  

Total

   $ 126,978    $ 112,500
    

  

 

For each of 2004 and 2003, audit services consisted of the audit of the Company’s annual consolidated financial statements and the review of the Company’s quarterly financial statements. Audit-related services included benefit plan audits. Tax services included federal and state tax compliance and research.

 

PROXIES AND VOTING AT THE MEETING

 

The expense of solicitation of proxies is to be paid by the Company. The Company will also reimburse brokerage houses and other custodians, nominees and fiduciaries for their reasonable expenses in sending proxies and proxy material to the beneficial owners of the Company’s common stock.

 

At the close of business on July 6, 2004, the record date for determination of stockholders entitled to vote at the annual meeting, there were 2,490,270 shares of common stock of the Company outstanding and entitled to vote.

 

Each share of common stock is entitled to one vote. Any stockholder giving a proxy has the power to revoke it at any time before it is voted, by written notice to the Secretary, by delivery of a later-dated proxy or in person at the meeting.

 

The holders of a majority of the total shares of common stock issued and outstanding, whether present in person or represented by proxy, will constitute a quorum for the transaction of business at the

 

15


meeting. The vote of a plurality of the shares represented at the meeting, in person or by proxy, is required to elect the two nominees for director. Approval of any other matter submitted to the stockholders for their consideration at the meeting requires the affirmative vote of the holders of a majority of the shares of common stock represented at the meeting, in person or by proxy, and entitled to vote. Abstentions, directions to withhold authority, and broker non-votes are counted as shares present in the determination of whether the shares of stock represented at the meeting constitute a quorum. Abstentions, directions to withhold authority, and broker non-votes are not counted in tabulations of the votes cast on proposals presented to stockholders. Thus, an abstention, direction to withhold authority, or broker non-vote with respect to a matter other than the election of directors, may have the same legal effect as a vote against the matter. With respect to the election of directors, an abstention, direction to withhold authority or broker non-vote will have no effect. An automated system administered by the Company’s transfer agent will be used to tabulate votes.

 

A stockholder entitled to vote for the election of directors can withhold authority to vote for either of the nominees.

 

STOCKHOLDER PROPOSALS

 

The deadline for receipt of stockholder proposals for inclusion in the Company’s 2005 proxy material is March 18, 2005. Any stockholder proposal should be submitted in writing to the Secretary of the Company at its principal executive offices. The stockholder proposal must include the stockholder’s name and address as it appears on the Company’s records and the number of shares of the Company’s common stock beneficially owned by such stockholder. In addition, (i) for proposals other than nominations for the election of directors, such notice must include a description of the business desired to be brought before the meeting, the reasons for presenting such business at the meeting, and any material interest of the stockholder in such business, and (ii) for proposals relating to stockholder nominations for the election of directors, such notice must also include, with respect to each person nominated, the information required by Regulation 14A under the Exchange Act. All other proposals to be presented at the meeting must be delivered to the Secretary of the Company, in writing, by June 3, 2005.

 

FINANCIAL STATEMENTS

 

The Company has enclosed its Annual Report to Stockholders for the fiscal year ended April 30, 2004 with this Proxy Statement. Stockholders are referred to the report for financial and other information about the Company, but such report is not incorporated in this Proxy Statement and is not a part of the proxy soliciting material.

 

OTHER MATTERS

 

Management of the Company knows of no other matters which are likely to be brought before the annual meeting. If any such matters are brought before the meeting, the persons named in the enclosed proxy will vote thereon according to their judgment.

 

By Order of the Board of Directors
/s/    D. MICHAEL PARKER        

D. MICHAEL PARKER

Secretary

 

July 16, 2004

 

16


APPENDIX A

 

CHARTER

 

OF THE AUDIT COMMITTEE

 

OF THE BOARD OF DIRECTORS

 

OF

 

KEWAUNEE SCIENTIFIC CORPORATION (the “Company”)

 

as amended June 22, 2004

 

I. Organization

 

The Audit Committee of the Board of Directors shall be comprised of at least three directors who are independent of management and the Company. Members of the Audit Committee shall be considered independent if they have no relationship to the Company that may interfere with the exercise of their independence from management and the Company, and shall otherwise satisfy the applicable membership requirements under the rules of the Nasdaq Stock Market. No member shall have a relationship with the company that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. Each Audit Committee member shall be financially literate, and at least one member shall be a “financial expert” as defined by the SEC.

 

II. Statement of Policy

 

The primary function of the Audit Committee is oversight. The Audit Committee shall provide assistance to the Board of Directors in fulfilling the Board’s responsibility to the Company’s shareholders, potential shareholders, and investment community relating to corporate accounting, reporting practices of the Company, the quality and integrity of financial reports regarding the Company, and compliance with the Company’s Code of Ethics. In doing so, it is the responsibility of the Audit Committee to maintain free and open communication between the directors, the independent auditors, and the senior management of the Company.

 

III. Meetings

 

The Audit Committee shall meet quarterly to review the financial results for the quarter before such results are released to the public and filed with the SEC, or more frequently as circumstances dictate. As part of its oversight function, the Audit Committee also shall meet at least annually with management and the independent auditors in separate executive sessions to discuss any matters that the Audit Committee or each of these groups believe should be discussed.

 

IV. Responsibilities and Duties

 

The Audit Committee’s responsibilities include overseeing the accounting and financial reporting processes and financial statement audits. The Audit Committee believes its policies and procedures should remain flexible, to best react to changing conditions and to reasonably ensure to the directors and shareholders that the corporate accounting and reporting practices of the Company are in accordance with all requirements and are of the highest quality.

 

A-1


In carrying out these responsibilities and duties, the Audit Committee shall:

 

  A. Audit Committee Charter/Report

 

  1. Review and reassess the Audit Committee Charter as conditions dictate, but no less frequently than annually, and request the Board to revise the Charter, as necessary.

 

  B. Independent Auditor

 

  1. Have sole authority to appoint, discharge and replace the independent auditor.

 

  2. Review the performance of the independent auditor at least annually.

 

  3. Establish a clear understanding with management and the independent auditor that the independent auditor is directly accountable to the Audit Committee.

 

  4. Preapprove all audit and permissible non-auditing services to be provided by the independent auditor for the Company and its subsidiaries and the fees (or the range of projected fees) and other compensation for such services (subject to a de minimis exception under the law), review the independent auditor’s proposed audit scope, and disclose to investors in periodic reports filed with the SEC all reportable fees and other compensation paid to the independent auditor.

 

  5. Review the independent auditor’s report on all relationships between the independent auditor and the Company to assess the auditor’s independence and consider whether there should be a regular rotation of the independent auditor to assure continuing auditor independence.

 

  6. Discuss with management and the independent auditor the Company’s annual and quarterly financial statements and any reports, earnings press releases or other financial information submitted to a governmental body or the public.

 

  7. Review the independent auditor’s reports describing (i) the Company’s critical accounting policies and practices to be used in the audit, (ii) the details of all alternative treatments of financial information within generally accepted accounting principles discussed with management, and (iii) all material written communications between the independent auditor and management.

 

  8. Review annually a report by the independent auditor describing that firm’s internal quality-control procedures and any material issues raised by the most recent internal quality-control review, or peer review of the independent auditor, or by any inquiry or investigation by governmental or professional authorities and any steps taken to deal with any issues.

 

  9. Consult and discuss with the independent auditor regarding internal controls, the fullness and accuracy of the Company’s financial statements and the matters required to be discussed by Statement of Auditing Standards No. 61.

 

  10. Require that the independent auditor inform the Audit Committee of any fraud or illegal acts which it believes exist, or deficiencies in internal controls.

 

  11.

Following completion of the annual audit, review separately with each of management and the independent auditors any significant difficulties encountered during the course of

 

A-2


 

the audit, including any restrictions on the scope of work or access to required information.

 

  12. Review and resolve any significant disagreements between management and the independent auditor in connection with the preparation of the financial statements.

 

C. Ethical and Legal Compliance

 

  1. Review with the Company’s counsel, legal compliance matters including corporate securities trading policies.

 

  2. Review with the Company’s counsel, any legal matter that could have a significant impact on the organization’s financial statements.

 

  3. Review and approve all related-party transactions.

 

  4. Review and assess periodically, and at least annually, the adequacy of the Code of Ethics approved by the Board, and recommend any modifications to the Code of Ethics to the Board for approval.

 

  5. Direct members of the Company’s senior management to report any violations of, or non-compliance with, the Code of Ethics to the Committee.

 

  6. If the need for independent counsel and other advisors is determined to be desirable in the performance of the Committee’s responsibilities, the Committee shall engage and determine funding for such counsel and advisors.

 

  7. Establish procedures for the receipt and treatment of complaints regarding accounting, internal accounting controls or audit matters and for confidential submissions by associates of concerns regarding questionable accounting or auditing matters.

 

While the Audit Committee has the responsibilities and duties set forth in this Charter, it is not the duty of the Audit Committee to plan or conduct audits or to determine that the Company’s financial statements are complete and accurate and are in accordance with generally accepted accounting principles. This is the responsibility of management and the independent auditor. Nor is it the duty of the Audit Committee to conduct investigations or to assure compliance with laws and regulations.

 

A-3


PROXY

 

KEWAUNEE SCIENTIFIC CORPORATION

2700 West Front Street

Statesville, North Carolina 28677-2927

 

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

 

The undersigned hereby appoints James T. Rhind, Wiley N. Caldwell and Silas Keehn as Proxies, each with power of substitution, and hereby authorizes them to represent and to vote, as designated on the reverse side hereof, all the shares of common stock of Kewaunee Scientific Corporation held of record by the undersigned on July 6, 2004, at the Annual Meeting of Stockholders to be held at 10:00 a.m., Central Daylight Time, on August 25, 2004 and at any adjournment thereof.

 

Your vote for two directors may be indicated on the reverse side. Margaret Barr Bruemmer and Eli Manchester, Jr. have been nominated for election as Class III Directors.

 

(Continued and to be signed on the reverse side)

 

Address Change/Comments (Mark the corresponding box on the reverse side)

 


This proxy when properly executed will be voted in the manner directed by the undersigned stockholder. If no direction is made, this proxy will be voted FOR the election of the nominees named in Item 1 below. Please mark your vote inside one box below.               

1.       Election of Class III Directors:

Margaret Barr Bruemmer and

Eli Manchester, Jr.

       

Please

Mark Here

for Address

Change or

Comments

  

 

¨

    
        SEE REVERSE SIDE          

FOR the nominees listed

above (except as

marked to the contrary)

  

WITHHOLD AUTHORITY

to vote for the nominees

listed above

                   
¨    ¨                    
If you wish to withhold authority for either of the nominees, write such nominee’s name in this space                    
                     

2.       In their discretion, the Proxies are authorized to vote upon such other business as may properly come before the Meeting.

         
         You are urged to date, sign and return promptly this proxy in the envelope provided. It is important for you to be represented at the Meeting. The execution of this proxy will not affect your right to vote in person if you are present at the Meeting and wish to so vote.    
         Date:                 , 2004
        
   
         Signature    
        
   
         Signature if held jointly    
         IMPORTANT: Please sign exactly as your name or names appear hereon. If signing as an attorney, executor, administrator, trustee, guardian, or in some other representative capacity, or as an officer of a corporation, please indicate your capacity or full title. If stock is held jointly, each joint owner should sign.